UNIXELL BIOTECHNOLOGY

unixell-biotechnology-logo

Yuesai Biotechnology is a cell therapy drug developer that uses human pluripotent stem cell technology. Yuesai Biotechnology develops stem cell therapy for neurodegenerative diseases, rare diseases, and tumors using its proprietary intellectual property rights of human pluripotent stem cell preparation, cultivation, differentiation, and gene editing technology platform.

#SimilarOrganizations #Financial #Website #More

UNIXELL BIOTECHNOLOGY

Industry:
Biotechnology

Founded:
2021-06-01

Address:
Pudong, Shandong, China

Country:
China

Website Url:
http://www.unixell.com

Total Employee:
11+

Status:
Active

Total Funding:
300 M CNY


Similar Organizations

avant-meats-logo

Avant Meats

Avant Meats is a technology company with patent-pending solutions to produce animal meat and protein without the animal

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

code-biotherapeutics-logo

Code Biotherapeutics

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

envirokure-incorporated-logo

EnviroKure, Incorporated

Disruptive ag biotechnology to enhance plant growth and productivity, builds healthy soil and can reduce the need for chemical fertilizers.

iecure-logo

iECURE

iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

spark-therapeutics-logo

Spark Therapeutics

Spark Therapeutics is focused on the development of gene therapy.

vivodyne-logo

Vivodyne

Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.

Investors List

casvc_image

CASVC

CASVC investment in Series A - UniXell Biotechnology

tasly-capital_image

Tasly Capital

Tasly Capital investment in Series A - UniXell Biotechnology

pudong-chuangtou_image

Pudong Chuangtou

Pudong Chuangtou investment in Series A - UniXell Biotechnology

kunlun_image

KUNLUN

KUNLUN investment in Seed Round - UniXell Biotechnology

tf-capital_image

TF Capital

TF Capital investment in Seed Round - UniXell Biotechnology

fosun-pharmaceutical_image

Fosun Pharma

Fosun Pharma investment in Seed Round - UniXell Biotechnology

ruihua-venture-capital_image

Ruihua Venture Capital

Ruihua Venture Capital investment in Seed Round - UniXell Biotechnology

cdh-investments_image

CDH Investments

CDH Investments investment in Seed Round - UniXell Biotechnology

hillhouse-investment_image

Hillhouse Investment

Hillhouse Investment investment in Seed Round - UniXell Biotechnology

sherpa-venture-capital_image

Sherpa Healthcare Partners

Sherpa Healthcare Partners investment in Seed Round - UniXell Biotechnology

Official Site Inspections

http://www.unixell.com

  • Host name: 36.138.223.14
  • IP address: 36.138.223.14
  • Location: China
  • Latitude: 34.7725
  • Longitude: 113.7266
  • Timezone: Asia/Shanghai

Loading ...

More informations about "UniXell Biotechnology"

UniXell - Crunchbase Company Profile & Funding

Organization. UniXell . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. UniXell develops cell therapies for the treatment …See details»

上海跃赛生物科技有限公司 - unixell.com

UniXell is an innovative biotechnology company specialized in developing hPSC based cell therapy products. Since its founding in 2021, Unixell has developed multiple key technology platforms, including Reprogramming technology, …See details»

UniXell Biotechnology 2025 Company Profile: Valuation, Funding ...

UniXell Biotechnology General Information Description. Developer of cellular therapy based on human pluripotent stem cells. The company focuses on unmet medical needs, including …See details»

UniXell Biotechnology - Products, Competitors, Financials, …

UniXell Biotechnology provides pharmaceutical solutions with a focus on developing a new generation of cell therapy drugs based on human pluripotent stem cells. It offers a …See details»

Shanghai Unixell Biotechnology Co. Ltd. - BioCentury Company …

Shanghai Unixell Biotechnology Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»

What is UniXell Biotechnology? Company Culture, Mission, Values

See what employees say it's like to work at UniXell Biotechnology. Salaries, reviews, and more - all posted by employees working at UniXell Biotechnology.See details»

上海跃赛生物科技有限公司

Oct 14, 2024 跃赛生物是一家专注于开发新一代基于人多能干细胞的细胞治疗药物的创新型制药公司。 自2021年创立以来,团队开发了重编程技术平台、干细胞分化平台、sisbar谱系示踪技 …See details»

UniXell - Crunchbase

UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.See details»

上海跃赛生物科技有限公司 - unixell.com

UniXell Biotechnology, a leading company in the field of human PSC derived cell therapy for neurological diseases, was founded in 2021 with R&D center and GMP facility covering a total …See details»

UniXell Biotechnology - Crunchbase Company Profile & Funding

Organization. UniXell Biotechnology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. UniXell Biotechnology is a new …See details»

UniXell - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Aug 1, 2021: Angel Round - …See details»

UniXell - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Organization. UniXell . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. Edit Patents and …See details»

UniXell DA-001 - Drug Targets, Indications, Patents - Synapse

UniXell DA-001, Initially developed by Shanghai Yusai Biotechnology Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System …See details»

上海跃赛生物科技有限公司 - unixell.com

上海跃赛生物科技有限公司,全球人多能干细胞来源神经系统疾病细胞疗法的领军企业,成立于2021年,在上海市自由贸易试验区自贸壹号生命科技产业园二期建有总面积约4000平米的研 …See details»

UniXell Biotechnology - Funding, Financials, Valuation & Investors

UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs. New. Resources. ... How much …See details»

UX-DA001 in Parkinson Disease, Idiopathic - ICH GCP

Dec 30, 2024 March 26, 2025 updated by: Shanghai UniXell Biotechnology Co., Ltd. An Exploratory Clinical Study to Evaluate UX-DA001 Injection (Human Midbrain Dopaminergic …See details»

Working at UniXell Biotechnology - Glassdoor

Glassdoor gives you an inside look at what it's like to work at UniXell Biotechnology, including salaries, reviews, office photos, and more. This is the UniXell Biotechnology company profile. …See details»

上海跃赛生物科技有限公司 - unixell.com

Mar 14, 2022 (UniXell), a leader in the field of pluripotent stem cell drug development, announced the completion of tens of millions of yuan angel round financing. This round of …See details»

Unixell-Bioinformatics - GitHub

GitHub is where Unixell-Bioinformatics builds software. GitHub is where Unixell-Bioinformatics builds software. Skip to content. Navigation Menu Toggle navigation. Sign in UnixellTest. …See details»

UniXell - Updates, News, Events, Signals & Triggers - Crunchbase

UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.See details»

linkstock.net © 2022. All rights reserved